Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 May;8(5):1781-1783.
doi: 10.4103/jfmpc.jfmpc_225_19.

Psychosis consequent to antimalarial drug use in a young child

Jitender Aneja  1 , Dheeraj Goya  1 , Bharat Choudhary  2
Affiliations
Case Reports

Psychosis consequent to antimalarial drug use in a young child

Jitender Aneja et al. J Family Med Prim Care. 2019 May.

Abstract

The empirical use of anti-malarial agents in patients of unexplained pyrexia is a common practice in developing countries especially where the prevalence of malaria is high. The use of artemisinin-based combined therapies has gained prominence since some time, but chloroquine is still commonly utilized as monotherapy or in combination. Neuropsychiatric adverse effects of artemisinin are rarely reported, while chloroquine is associated with a range of such events. Further, the reporting of such side effects was more so in the 1980s and 1990s, and with the turn of this century, very few cases of chloroquine-induced psychosis especially in child and adolescent population have been reported. Herein, we report the development of psychosis in a young child who was exposed to chloroquine.

Keywords: Antimalarial drugs; artesunate; chloroquine; malaria; psychosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nevin LR, Croft AM. Psychiatric effects of malaria and anti-malarial drugs: Historical and modern perspectives. Malar J. 2016;15:332. - PMC - PubMed
    1. Taylor WR, While NJ. Antimalarial drug toxicity. Drug Safety. 2004;27:25–61. - PubMed
    1. Schneider C, Adamcova M, Jick SS, Schlagenhauf P, Miller MK, Rhein HG, et al. Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders. Travel Med Infect Dis. 2013;11:71–80. - PubMed
    1. Grabias B, Kumar S. Adverse neuropsychiatric effects of antimalarial drugs. Exp Opin Drug Safety. 2016;15:903–10. - PubMed
    1. Sheehan DV, Sheehan KH, Shytle RD, Janavas J, Bannon Y, Rogers JE, et al. Reliability and validity of the mini international neuropsychiatric interview for children and adolescents (MINI-KID) J Clin Psychiatry. 2010;71:313–26. - PubMed

Publication types